Marchal Corynne, Eberst Guillaume, Calais François, Westeel Virginie, Malouf Reem
Marie & Louis Pasteur University, Besançon, France.
Department of Chest Diseases and Thoracic Oncology, University Hospital of Besançon, Besançon, France.
Cochrane Database Syst Rev. 2025 May 19;5(5):CD015819. doi: 10.1002/14651858.CD015819.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To compare, via a network meta-analysis, the effectiveness and safety of different immunotherapy agents that are administered in a perioperative setting to people with resectable non small-cell lung cancer To perform indirect comparisons in order to generate a clinically meaningful hierarchy of perioperative strategies of immunotherapy administration for overall survival in operable people with resectable non small-cell lung cancer.
这是一项Cochrane系统评价（干预措施）的方案。目标如下：通过网络荟萃分析，比较在围手术期给予可切除非小细胞肺癌患者不同免疫治疗药物的有效性和安全性；进行间接比较，以便为可切除非小细胞肺癌的可手术患者生成关于围手术期免疫治疗总体生存策略的具有临床意义的等级排序。
